Abstract Background: There are no prior studies investigating the attitudes and knowledge of opioid treatment program (OTP) clinicians on prescribed…
Abstract Background: People who use cannabis medically do so more frequently than those who use nonmedically, potentially placing them at…
Abstract Introduction: There are no prior studies investigating the perspectives of Opioid Treatment Program (OTP) clinicians on clients’ cannabis use.…
Abstract Background: Cannabis was legalised for medical purposes in 2016. Uptake was initially slow, but since 2019 there has been…
Abstract The underlying neurobiological mechanisms of cannabidiol’s (CBD) management of alcohol use disorder (AUD) remains elusive. Aim We conducted a…
Abstract Background: Cannabis use disorder (CUD) is increasingly common and contributes to a range of health and social problems. Cannabidiol…
Abstract Introduction: Prescribed medicinal cannabis (MC) is an increasingly common prescription in Australia for treating pain, anxiety, and sleep disorders.…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s42238-023-00202-y. Article type: Research Article Keywords: Medical cannabis, THC,…
Abstract Introduction: Sleep disorders are the third most common indication for the prescription of medical cannabis products in Australia, after…
Abstract Introduction and aims: There is increasing interest and evidence for the use of cannabinoid medications in the treatment of…